Advertisement

Angiogenesis

, Volume 18, Issue 2, pp 201–207 | Cite as

Diabetes mellitus and female gender are the strongest predictors of poor collateral vessel development in patients with severe coronary artery stenosis

  • Ertan Yetkin
  • Ergun Topal
  • Nuri Erguzel
  • Kubilay Senen
  • Gulumser Heper
  • Johannes Waltenberger
Original Paper

Abstract

Background

Coronary collateral vessel development (CVD), i.e., arteriogenesis, is regarded as one of the most important mechanisms—along with angiogenesis—to result in protection of the myocardium. Coronary CVD is associated with a reduction in infarct size, future cardiovascular events and improved survival in patients with occlusive coronary artery disease by enhancing regional perfusion in the chronically ischemic myocardium. In the present study, we aimed to investigate the relation of cardiovascular risk factors and hematological parameters with collateral development in patients with severely stenotic (≥95 %) and totally occluded coronary artery disease including at least one major coronary artery.

Materials and methods

The study population was selected from the patients who underwent coronary angiography between January 2008 and March 2009. Five hundred and two patients who had at least one coronary artery stenosis ≥95 % (368 men; mean age 59 ± 10 years) comprised the study population. Of the 502 patients, 228 had total occlusion in at least one major epicardial coronary artery. Collateral artery grading was performed by using Cohen–Rentrop method to the vessel with coronary artery stenosis of ≥95 % and patients with chronic total occlusions (CTO). Patients with grade 0–1 collateral development were regarded as the poor collateral group, and patients with grade 2–3 collateral development were regarded as the good collateral group.

Results

Two hundred and fifty-eight (51 %) of 502 patients had poor collateral development, and 244 (49 %) had good collateral development. Logistic regression analysis revealed that DM was independently associated with poor CVD in patients with ≥95 % stenosis (p < 0.001). Additionally, female gender and DM were found to be independently associated with poor CVD in patients with CTO (p = 0.005 and p < 0.001, respectively). Monocyte count was found to be independent of CVD neither in patients with ≥95 % stenosis nor in patients with CTO.

Conclusion

Our data show that DM is an independent factor for poor coronary CVD both in patients with severe coronary artery stenosis and in patients with CTO. Female gender or being in post-menopausal period is another negative risk factor for poor CVD in addition to DM in patients with CTO.

Keywords

Arteriogenesis Diabetes mellitus Collateral vessel Gender 

References

  1. 1.
    Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101:40–50CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Khmelewski E, Becker A, Meinertz T, Ito WD (2004) Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res 95:E56–E64CrossRefPubMedGoogle Scholar
  3. 3.
    Billinger M, Kloos P, Eberli FR et al (2002) Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow up study in 403 patients with coronary artery disease. J Am Coll Cardiol 40:1545–1550CrossRefPubMedGoogle Scholar
  4. 4.
    Habib GB, Heibig J, Forman SA et al (1991) Influence of coronary collateral vessels on myocardial infarct size in humans: results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI investigators. Circulation 83:739–746CrossRefPubMedGoogle Scholar
  5. 5.
    Hansen JF (1989) Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 117:290–295CrossRefPubMedGoogle Scholar
  6. 6.
    Abaci A, Oğuzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, Ergin A (1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99:2239–2242CrossRefPubMedGoogle Scholar
  7. 7.
    Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I (2005) Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis 16:281–285CrossRefPubMedGoogle Scholar
  8. 8.
    Zbinden R, Zbinden S, Billinger M, Windecker S, Meier B, Seiler C (2005) Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy. Heart 91:1289–1293CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Heil M, Eitenmüller I, Schmitz-Rixen T, Schaper W (2006) Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10:45–55CrossRefPubMedGoogle Scholar
  10. 10.
    Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Cengel A (2008) Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis 197:753–756CrossRefPubMedGoogle Scholar
  11. 11.
    Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5:587–592CrossRefPubMedGoogle Scholar
  12. 12.
    Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, Kuethe F, Ferrari M, Figulla HR (2004) Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 110:1940–1945CrossRefPubMedGoogle Scholar
  13. 13.
    de Vries J, Anthonio RL, van den Heuvel AF, Tan ES, Jessurun GA, de Smet BJ, DeJongste MJ, Zijlstra F (2007) Incidence and angiographic predictors of collateral function in patients with stable coronary artery disease scheduled for percutaneous coronary intervention. Catheter Cardiovasc Interv 70:197–202CrossRefPubMedGoogle Scholar
  14. 14.
    Fujita M, Nakae I, Kihara Y, Hasegawa K, Nohara R, Ueda K, Tamaki S, Otsuka K, Sasayama S (1999) Determinants of collateral development in patients with acute myocardial infarction. Clin Cardiol 22:595–599CrossRefPubMedGoogle Scholar
  15. 15.
    Nathoe HM, Koerselman J, Buskens E, van Dijk D, Stella PR, Plokker TH, Doevendans PA, Grobbee DE, de Jaegere PP (2006) Determinants and prognostic significance of collaterals in patients undergoing coronary revascularization. Am J Cardiol 98:31–35CrossRefPubMedGoogle Scholar
  16. 16.
    Kyriakides ZS, Psychari S, Chrysomallis N, Georgiadis M, Sbarouni E, Kremastinos DT (2002) Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty. Heart 87:61–66CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Seiler C (2010) The human coronary collateral circulation. Eur J Clin Invest 40:465–476CrossRefPubMedGoogle Scholar
  18. 18.
    Werner GS, Richartz BM, Heinke S, Ferrari M, Figulla HR (2003) Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 24(1134):1142Google Scholar
  19. 19.
    Waltenberger J (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49:554–560CrossRefPubMedGoogle Scholar
  20. 20.
    Waltenberger J, Lange J, Kranz A (2000) Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 102:185–190CrossRefPubMedGoogle Scholar
  21. 21.
    Tchaikovski V, Olieslagers S, Böhmer FD, Waltenberger J (2009) Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Circulation 120:150–159CrossRefPubMedGoogle Scholar
  22. 22.
    Czepluch FS, Waltenberger J (2008) Monocyte function rather than number is a prerequisite for the stimulation of collateral growth. Atherosclerosis 196:485–486CrossRefPubMedGoogle Scholar
  23. 23.
    Schaper W (1993) Coronary collateral development: concepts and hypotheses. In: Schaper W, Schaper J (eds) Collateral circulation: heart, brain, kidney, limbs. Kluwer Academic Publishers, Boston, pp 41–64CrossRefGoogle Scholar
  24. 24.
    Hoefer IE, van Royen N, Rectenwald JE et al (2004) Arteriogenesis proceeds via ICAM-l/Mac-1-mediated mechanisms. Circ Res 94:1179–1185CrossRefPubMedGoogle Scholar
  25. 25.
    Hoefer IE, Grundmann S, van Royen N, Voskuil M, Schirmer SH, Ulusans S, Bode C, Buschmann IR, Piek JJ (2005) Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 181:285–293CrossRefPubMedGoogle Scholar
  26. 26.
    Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829–837CrossRefPubMedGoogle Scholar
  27. 27.
    Heil M, Ziegelhoeffer T, Pipp F et al (2002) Blood monocyte concentration is critical for the enhancement of collateral artery growth (arteriogenesis). Am J Physiol Heart Circ Physiol 283:H2411–H2419CrossRefPubMedGoogle Scholar
  28. 28.
    Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM, Jost MM, Aharinejad S, Hartmann S, Buschmann IR (2006) Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 80:59–65CrossRefPubMedGoogle Scholar
  29. 29.
    Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM (1999) Sex-based differences in early mortality after myocardial infarction. National Registry of myocardial infarction 2 participants. N Engl J Med 341:217–225CrossRefPubMedGoogle Scholar
  30. 30.
    Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, New G, Grines CL, Pietras CG, Kern MJ, Ferrell M, Leon MB, Mehran R, White C, Mieres JH, Moses JW, Stone GW, Jacobs AK, American College of Cardiology Foundation; American Heart Association (2005) Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 111:940–953CrossRefPubMedGoogle Scholar
  31. 31.
    Kyriakides ZS, Petinakis P, Kaklamanis L, Lyras T, Sbarouni E, Karayannakos P, Iliopoulos D, Kremastinos DT (2003) Gender does not influence angiogenesis and arteriogenesis in a rabbit model of chronic hind limb ischemia. Int J Cardiol 92:83–91CrossRefPubMedGoogle Scholar
  32. 32.
    Lamping KG, Christensen LP, Tomanek RJ (2003) Estrogen therapy induces collateral and microvascular remodeling. Am J Physiol Heart Circ Physiol 285:H2039–H2044CrossRefPubMedGoogle Scholar
  33. 33.
    Mouquet F, Cuilleret FJ, Susen S, Ennezat PV, Letourneau T, Doevendans PAM et al (2009) Collateral vessel formation in patients with documented coronary occlusion: role of gender, smoking and of their combination. Eur Heart J 30(Abstract Supplement):357Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Ertan Yetkin
    • 1
    • 2
    • 3
  • Ergun Topal
    • 3
  • Nuri Erguzel
    • 1
  • Kubilay Senen
    • 1
  • Gulumser Heper
    • 1
  • Johannes Waltenberger
    • 2
    • 4
    • 5
  1. 1.Faculty of Medicine, Department of CardiologyAbant Izzet Baysal UniversityBoluTurkey
  2. 2.Department of CardiologyMaastricht University Medical CentreMaastrichtThe Netherlands
  3. 3.International Medical Center Division of CardiologyMersinTurkey
  4. 4.Department of Cardiovascular MedicineUniversity of MuensterMuensterGermany
  5. 5.Cells-in-Motion Cluster of Excellence (EXC 1003 – CiM)University of MuensterMuensterGermany

Personalised recommendations